PERCORTEN®-V (desoxycorticosterone pivalate)

Addressing the challenge of canine Addison’s disease

Canine Addison’s disease is complex, and is often confused with other conditions because the symptoms are so variable. If left untreated, it can be fatal. The most common signs include1

  • Lethargy/depression
  • Weakness
  • Dehydration
  • Vomiting
  • Diarrhea
  • Weight loss
  • Lack of appetite

Veterinarians choose PERCORTEN®-V (desoxycorticosterone pivalate) because it is

  • The first veterinary product approved by the FDA for the treatment of canine Addison’s disease
  • Fast-acting, safe and effective
  • Only administered once every 25 days

Important Safety Information

The most common adverse reactions reported are depression/lethargy, vomiting, anorexia, polydipsia and polyuria. Like other adrenocortical hormones, Percorten-V may cause severe side effects if dosage is too high or prolonged. Some of these effects may resolve with adjustments in dose or interval of Percorten-V or concomitant glucocorticoid administration. Do not use in pregnant dogs or in dogs that are suffering from congestive heart disease, severe renal disease or edema. Please see the product insert for full product information.

Percorten-V is indicated for use as replacement therapy for the mineralocorticoid deficit in dogs with primary adrenocortical insufficiency.

1. Van Lanen, K., Sande A. 2014. “Canine hypoadrenocorticism: pathogenesis, diagnosis, and treatment.” Top. Companion Anim. Med. 29(4):88–95.